Table 1 : Serum Annexin A2 (ANXA2) and Alpha fetoprotein (AFA)
in different studied groups compared to the healthy control group.


ANXA2

Group n ng/ml P-value

Control
Chronic hepatitis
Fibrosis
Cirrhosis
Early HCC
Late HCC
40
6
8
6
8
12
10.67±2.89
11.78±1.40
16.34±3.96
18.45±3.27
33.85±3.59
36.89±5.22
--
P=0.583
P<0.03*
P<0.04*
P<0.000***
P<0.000***

AFP

Group n IU/ml P-value

Control
Chronichepatitis
Fibrosis
Cirrhosis
Early HCC
Late HCC
40
6
8
6
8
12
4.02 ±0.97
17.45±2.33
21.65±4.65
37.45±2.92
39.34±4.57
320.23±13.68
--
P<0.02*
P<0.001**
P<0.001**
P<0.001**
P<0.000***

Abdelgawad et al.Journal of Cancer Therapeutics and Research  2017 6:2DOI : 10.7243/2049-7962-6-2